Fraunhofer in effort to develop robotic plant-based vax facility

The Fraunhofer Center for Molecular Biotechnology and its Center for Manufacturing Innovation have teamed with iBio Inc to develop an automated, scalable factory of sorts that uses plants for weeks-long vaccine production. Robotically tended machines plant seeds, nurture growing plants, introduce a viral vector to stimulate plant production of a target protein, and then harvest the biomass. Announcement

Suggested Articles

The FDA has slapped the parent of Dollar Tree stores with a warning letter saying some CMOs that made its OTC products were among the world's worst.

GSK expects Shingrix supplies to rise slightly in 2020, but the real "step change" will come in 2024 with a brand-new manufacturing facility.

Continuing its expansion efforts, Japan’s Fujifilm will make a major investment in its U.S. gene therapy operation in Texas.